Hôpital Maisonneuve-Rosemont
Explore healthcare research opportunities at a hospital
At a glance
Eligible Funding
- No Condition
Timeline
- Open Date : February 08, 2022
Financing Type
Researchers And Facilities
Eligible Industries
- All industries
Grant Providers
- Cognit.ca
- Hôpital Maisonneuve-Rosemont
Status
Open
Overview
Get access to world-class expertise, facilities and IP when you form a partnership with a university, college or health institution. Use the partnership to help solve complex problems, build proofs-of-concept, improve processes and performance, validate y
Eligibility criteria
Eligibility criteria for this grant:
- Applicants must be residents of the specified region.
- Applicants must meet the income requirements.
Evaluation & selection criteria
There are evaluation and selection criteria for this grant. Here is a short summary:
- Submissions will be evaluated based on scientific merit, feasibility, methodology, impact, and alignment with the grant objectives.
- Applicants must demonstrate a clear research plan, strong methodology, feasibility of the project, and the potential impact of the research.
Apply to this program
Operating Grant: Extended prophylaxis comparing low molecular weight heparin (LMWH) to aspirin in total hip arthroplasty (EPCAT study)
Operating Grant: Extended prophylaxis comparing low molecular weight heparin (LMWH) to aspirin in total hip arthroplasty (EPCAT study)
The Operating Grant for the EPCAT study focuses on comparing extended prophylaxis using low molecular weight heparin (LMWH) versus aspirin in total hip arthroplasty. This research project aims to evaluate the effectiveness and safety of these two prophylactic treatments to prevent complications post-surgery, particularly in the context of total hip arthroplasty. Through rigorous clinical trials and data analysis, the study seeks to provide valuable insights that can potentially improve post-surgery care and outcomes for patients undergoing total hip arthroplasty.